News
BioPharma Credit PLC - Update on New Investment
BPCR is the lead investor and collateral agent for the US $316 million loan and invested US $194 million alongside co-investors providing US $122 million. Sebela Pharmaceuticals is a private specialty pharmaceutical company focused on gastro-intestinal medicines, dermatology, and women's health with pro-forma sales of approximately $250 million.
BPCR is the lead investor and collateral agent for the US $316 million loan and invested US $194 million alongside co-investors providing US $122 million. Sebela Pharmaceuticals is a private specialty pharmaceutical company focused on gastro-intestinal medicines, dermatology, and women's health with pro-forma sales of approximately $250 million.